Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 17,202 shares at $8.36 ($144K) on 2026-05-01, disclosed to the SEC on 2026-05-04.
Scheduled sale ($144k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.36 | 16,145 | $135K | 93.4% |
| 2 | $8.97 | 1,057 | $9K | 6.6% |
| Total | $8.40 avg | 17,202 | $144K | 100% |
| Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |
| EBS | SELL | 2024-05-23 | $6K | — | Filing → |